IMPAACT P1085: Human Papilloma Virus (HPV) Type-Specific Antibody

Completed

Conditions studied: Papilloma Virus, Human

In brief

This study is being done to evaluate how long the immune response from the Human Papilloma Virus (HPV) vaccine you / your child received persists. The immune response occurred after immunization and is what protects you/your child from HPV disease. You / your child received this vaccine as part of an earlier study (P1047). The vaccine is called Human Papillomavirus Vaccine (QHPV Vaccine, also known as GARDASIL®). The study will check to see if the protective effects (called "antibodies") produced by the vaccine have lasted, and for how long these effects will continue to last. You will not be given any medications or vaccines as part of this follow-up study.

Key facts

Study ID

NCT01206556

Run by

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

People needed

97

Starts

2010-05-01

Expected to finish

2013-08-01

Last updated by the study team

2015-04-01

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Previous enrollment in P1047
• Completion of the P1047 scheduled vaccine doses for their designated arm.
• Parent or legal guardian able and willing to provide signed informed consent
• Subjects should be between 1 and 2 years following their last HPV vaccination.

You may not qualify if…

• Any clinically significant diseases (other than HIV infection) or clinically significant findings during the screening medical history or physical examination that, in the investigator's opinion, would compromise the outcome of this study.
• Administration of a globulin-containing product within 90 days prior to enrollment.
• Receipt of an additional dose of Merck HPV vaccine other than that administered for the P1047 study.
• Receipt of GSK HPV vaccine.

Where it is running

• Miller Children's Hospital Long Beach (5093) — Long Beach, California, United States
• USC/Los Angeles County Medical Center NICHD CRS (5048) — Los Angeles, California, United States
• UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601) — Los Angeles, California, United States
• Univ of California, San Diego (4601) — San Diego, California, United States
• Univ. of California San Francisco NICHD CRS — San Francisco, California, United States
• Univ. of Colorado Denver NICHD CRS (5052) — Aurora, Colorado, United States
• Children's National Med. Ctr. Washington DC NICHD CRS (5015) — Washington D.C., District of Columbia, United States
• South Florida CDC Ft. Lauderdale NICHD CRS (5055) — Fort Lauderdale, Florida, United States
• Univ of Miami Pediatric/Perinatal HIV/AIDS (4201) — Miami, Florida, United States
• Rush University Cook County Hospital NICHD CRS (5083) — Chicago, Illinois, United States
• Chicago Children's CRS (4001) — Chicago, Illinois, United States
• Children's Hospital of Boston (5009) — Boston, Massachusetts, United States
• Boston Medical Center Ped. HIV Program NICHD CRS (5011) — Boston, Massachusetts, United States
• WNE Maternal Pediatric Adolescent AIDS CRS (7301) — Worcester, Massachusetts, United States
• Wayne State University/Children's Hospital of Michigan NICHD CRS (5041) — Detroit, Michigan, United States
• New Jersey Medical School (NJ) (2802) — Newark, New Jersey, United States
• New York University NY (5012) — New York, New York, United States
• Strong Memorial Hospital, University of Rochester NICHD CRS (5057) — Rochester, New York, United States
• SUNY Stony Brook (5040) — Stony Brook, New York, United States
• Bronx-Lebanon Hospital (6901) — The Bronx, New York, United States
• Jacobi Medical Center Bronx (5013) — The Bronx, New York, United States
• Texas Children's Hosp / Baylor Univ (3801) — Houston, Texas, United States
• San Juan City Hosp. PR NICHD CRS (5031) — San Juan, Puerto Rico

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.